Ipca Laboratories bags award for supply of anti-malarial medicines

13 Nov 2017 Evaluate

Ipca Laboratories has been selected by The Global Fund as their Panel Supplier of anti-malarial medicines for the Global Fund Pooled Procurement Mechanism and for the Private Sector Co-Payment Mechanism for an initial period of three years.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.



Ipca Laboratories Share Price

1463.05 -22.55 (-1.52%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×